Jeena Sikho Lifecare Limited
Fundamental Score
Jeena Sikho Lifecare Limited Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of JSLL across key market metrics for learning purposes.
Positive Indicators
11 factors identified
Strong Return on Equity (37.93%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (50.24%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Strong Operating Margins (23.44%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.
Robust Profit Growth (134.85%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (70.05%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (37.81% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Strong Profit Growth Track Record (72.79% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Conservative Debt Levels (D/E: 0.30)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Strong Interest Coverage (33.81x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (63.61%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
6 factors identified
Premium Valuation Risk (P/E: 58.20x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.
Weak Earnings Growth (-35.51% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.
Negative Free Cash Flow (₹-21.82 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 6.74%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Very High P/E Ratio
Observation: Significant overvaluation risk present.
Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.
Financial Statements
Comprehensive financial data for Jeena Sikho Lifecare Limited
About JSLL
Business Overview
Jeena Sikho Lifecare Limited trades in ayurvedic medicines in India. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support centre services. In addition, the company operates clinics under the Shuddhi Ayurveda, Shuddhi Clinics, Hospital & Institution of Integrated Medical Sciences, Shuddhi Wellness Clinics & Hospital, Shuddhi Ayurveda Panchakarma Hospital, and Shuddhi Panchakarma Day Care Clinic names. Jeena Sikho Lifecare Limited was founded in 2009 and is headquartered in Zirakpur, India.
Company Details
Key Leadership
Corporate Events
JSLL Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Jeena Sikho Lifecare Limited (JSLL)?
As of 29 Jan 2026, 10:36 am IST, Jeena Sikho Lifecare Limited (JSLL) is currently trading at ₹650.45. The stock has a market capitalization of ₹8.96K (Cr).
Is JSLL share price Overvalued or Undervalued?
JSLL is currently trading at a P/E ratio of 58.20x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.
What factors affect the Jeena Sikho Lifecare Limited share price?
Key factors influencing JSLL's price include its quarterly earnings growth (Sales Growth: 70.05%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Jeena Sikho Lifecare Limited a good stock for long-term investment?
Jeena Sikho Lifecare Limited shows a 5-year Profit Growth of 72.79% and an ROE of 37.93%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.30 before investing.
How does Jeena Sikho Lifecare Limited compare with its industry peers?
Jeena Sikho Lifecare Limited competes with major peers in the Pharmaceuticals. Investors should compare JSLL's P/E of 58.20x and ROE of 37.93% against the industry averages to determine its competitive standing.
What is the P/E ratio of JSLL and what does it mean?
JSLL has a P/E ratio of 58.20x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹58 for every ₹1 of annual earnings.
How is JSLL performing according to Bull Run's analysis?
JSLL has a Bull Run fundamental score of 60.8/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does JSLL belong to?
JSLL operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Jeena Sikho Lifecare Limited.
What is Return on Equity (ROE) and why is it important for JSLL?
JSLL has an ROE of 37.93%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Jeena Sikho Lifecare Limited generates profits from shareholders' equity.
How is JSLL's debt-to-equity ratio and what does it indicate?
JSLL has a debt-to-equity ratio of 0.30, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is JSLL's dividend yield and is it a good dividend stock?
JSLL offers a dividend yield of 0.15%, which means you receive ₹0.15 annual dividend for every ₹100 invested.
How has JSLL grown over the past 5 years?
JSLL has achieved 5-year growth rates of: Sales Growth 37.81%, Profit Growth 72.79%, and EPS Growth -35.51%.
What is the promoter holding in JSLL and why does it matter?
Promoters hold 63.61% of JSLL shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is JSLL's market capitalization category?
JSLL has a market capitalization of ₹8959 crores, placing it in the Mid-cap category.
How volatile is JSLL stock?
JSLL has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for JSLL?
JSLL has a 52-week high of ₹N/A and low of ₹N/A.
What is JSLL's operating profit margin trend?
JSLL has a 5-year average Operating Profit Margin (OPM) of 23.44%, indicating the company's operational efficiency.
How is JSLL's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 70.05% and YoY Profit Growth of 134.85%.
What is the institutional holding pattern in JSLL?
JSLL has FII holding of 6.59% and DII holding of 0.15%. Significant institutional holding often suggests professional confidence in the stock.